BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Groeger D, O'Mahony L, Murphy EF, Bourke JF, Dinan TG, Kiely B, Shanahan F, Quigley EM. Bifidobacterium infantis 35624 modulates host inflammatory processes beyond the gut. Gut Microbes 2013;4:325-39. [PMID: 23842110 DOI: 10.4161/gmic.25487] [Cited by in Crossref: 261] [Cited by in F6Publishing: 263] [Article Influence: 26.1] [Reference Citation Analysis]
Number Citing Articles
1 Kim JG, Zhang A, Rauseo AM, Goss CW, Mudd PA, O'Halloran JA, Wang L. The salivary and nasopharyngeal microbiomes are associated with SARS-CoV-2 infection and disease severity. J Med Virol 2022;95. [PMID: 36583481 DOI: 10.1002/jmv.28445] [Reference Citation Analysis]
2 Zhao Q, Yu J, Zhou H, Wang X, Zhang C, Hu J, Hu Y, Zheng H, Zeng F, Yue C, Gu L, Wang Z, Zhao F, Zhou P, Zhang H, Huang N, Wu W, Zhou Y, Li J. Intestinal dysbiosis exacerbates the pathogenesis of psoriasis-like phenotype through changes in fatty acid metabolism. Signal Transduct Target Ther 2023;8:40. [PMID: 36710269 DOI: 10.1038/s41392-022-01219-0] [Reference Citation Analysis]
3 Corrie L, Awasthi A, Kaur J, Vishwas S, Gulati M, Kaur IP, Gupta G, Kommineni N, Dua K, Singh SK. Interplay of Gut Microbiota in Polycystic Ovarian Syndrome: Role of Gut Microbiota, Mechanistic Pathways and Potential Treatment Strategies. Pharmaceuticals 2023;16:197. [DOI: 10.3390/ph16020197] [Reference Citation Analysis]
4 Li M, Ding J, Stanton C, Ross RP, Zhao J, Yang B, Chen W. Bifidobacterium longum subsp. infantis FJSYZ1M3 ameliorates DSS-induced colitis by maintaining the intestinal barrier, regulating inflammatory cytokines, and modifying gut microbiota. Food Funct 2023;14:354-68. [PMID: 36511157 DOI: 10.1039/d2fo03263e] [Reference Citation Analysis]
5 Mazziotta C, Tognon M, Martini F, Torreggiani E, Rotondo JC. Probiotics Mechanism of Action on Immune Cells and Beneficial Effects on Human Health. Cells 2023;12. [PMID: 36611977 DOI: 10.3390/cells12010184] [Reference Citation Analysis]
6 Mandal S, Mandal NC. Current trends and future perspectives of probiotics on human health: an overview. Recent Advances and Future Perspectives of Microbial Metabolites 2023. [DOI: 10.1016/b978-0-323-90113-0.00005-5] [Reference Citation Analysis]
7 Groeger D, Murphy EF, Tan HTT, Larsen IS, O'Neill I, Quigley EMM. Interactions between symptoms and psychological status in irritable bowel syndrome: An exploratory study of the impact of a probiotic combination. Neurogastroenterol Motil 2023;35:e14477. [PMID: 36178333 DOI: 10.1111/nmo.14477] [Reference Citation Analysis]
8 Noshadi N, Heidari M, Naemi Kermanshahi M, Zarezadeh M, Sanaie S, Ebrahimi-mameghani M. Effects of Probiotics Supplementation on CRP, IL-6, and Length of ICU Stay in Traumatic Brain Injuries and Multiple Trauma Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Evidence-Based Complementary and Alternative Medicine 2022;2022:1-14. [DOI: 10.1155/2022/4674000] [Reference Citation Analysis]
9 Luan M, Niu M, Yang P, Han D, Zhang Y, Li W, He Q, Zhao Y, Mao B, Chen J, Mou K, Li P. Metagenomic sequencing reveals altered gut microbial compositions and gene functions in patients with non-segmental vitiligo.. [DOI: 10.21203/rs.3.rs-2275067/v1] [Reference Citation Analysis]
10 Berryman MA, Milletich PL, Petrone JR, Roesch LF, Ilonen J, Triplett EW, Ludvigsson J. Autoimmune-associated genetics impact probiotic colonization of the infant gut. J Autoimmun 2022;133:102943. [PMID: 36356550 DOI: 10.1016/j.jaut.2022.102943] [Reference Citation Analysis]
11 Zanesco S, Hall W, Gibson R, Griffiths C, Maruthappu T. Approaches to nutrition intervention in plaque psoriasis, a multi-system inflammatory disease-The Diet and Psoriasis Project (DIEPP). Nutr Bull 2022;47:524-37. [PMID: 36082746 DOI: 10.1111/nbu.12580] [Reference Citation Analysis]
12 Yu J, Zhao Q, Wang X, Zhou H, Hu J, Gu L, Hu Y, Zeng F, Zhao F, Yue C, Zhou P, Li G, Li Y, Wu W, Zhou Y, Li J. Pathogenesis, multi-omics research, and clinical treatment of psoriasis. J Autoimmun 2022;133:102916. [PMID: 36209691 DOI: 10.1016/j.jaut.2022.102916] [Reference Citation Analysis]
13 Xu Z, Jiang N, Xiao Y, Yuan K, Wang Z. The role of gut microbiota in liver regeneration. Front Immunol 2022;13. [DOI: 10.3389/fimmu.2022.1003376] [Reference Citation Analysis]
14 Yang J, Qin S, Zhang H. Precise strategies for selecting probiotic bacteria in treatment of intestinal bacterial dysfunctional diseases. Front Immunol 2022;13:1034727. [DOI: 10.3389/fimmu.2022.1034727] [Reference Citation Analysis]
15 Controne I, Scoditti E, Buja A, Pacifico A, Kridin K, Fabbro MD, Garbarino S, Damiani G. Do Sleep Disorders and Western Diet Influence Psoriasis? A Scoping Review. Nutrients 2022;14:4324. [PMID: 36297008 DOI: 10.3390/nu14204324] [Reference Citation Analysis]
16 Sidenkova AP, Myakotnykh VS, Voroshilina ES, Melnik AA, Borovkova TA, Proshchenko DA. Mechanisms of Influence of Intestinal Microbiota on the Processes of Aging of the CNS and the Formation of Cognitive Disorders in Alzheimer’s Disease. Psychiatry 2022;20:98-111. [DOI: 10.30629/2618-6667-2022-20-3-98-111] [Reference Citation Analysis]
17 Lv L, Ruan G, Ping Y, Cheng Y, Tian Y, Xiao Z, Zhao X, Chen D, Wei Y. Clinical study on sequential treatment of severe diarrhea irritable bowel syndrome with precision probiotic strains transplantation capsules, fecal microbiota transplantation capsules and live combined bacillus subtilis and enterococcus faecium capsules. Front Cell Infect Microbiol 2022;12:1025889. [DOI: 10.3389/fcimb.2022.1025889] [Reference Citation Analysis]
18 Zeng L, Deng Y, He Q, Yang K, Li J, Xiang W, Liu H, Zhu X, Chen H. Safety and efficacy of probiotic supplementation in 8 types of inflammatory arthritis: A systematic review and meta-analysis of 34 randomized controlled trials. Front Immunol 2022;13:961325. [DOI: 10.3389/fimmu.2022.961325] [Reference Citation Analysis]
19 Štofilová J, Kvaková M, Kamlárová A, Hijová E, Bertková I, Guľašová Z. Probiotic-Based Intervention in the Treatment of Ulcerative Colitis: Conventional and New Approaches. Biomedicines 2022;10:2236. [DOI: 10.3390/biomedicines10092236] [Reference Citation Analysis]
20 Sangkanjanavanich S, Pradubpongsa P, Mitthamsiri W, Sangasapaviliya A, Boonpiyathad T. Bifidobacterium infantis 35624 efficacy in patients with uncontrolled asthma: A randomized placebo-controlled trial. Ann Allergy Asthma Immunol 2022:S1081-1206(22)01712-4. [PMID: 36089255 DOI: 10.1016/j.anai.2022.08.1000] [Reference Citation Analysis]
21 Lyu X, Chen J, Gao X, Yang J. Emerging story of gut dysbiosis in spondyloarthropathy: From gastrointestinal inflammation to spondyloarthritis. Front Cell Infect Microbiol 2022;12:973563. [DOI: 10.3389/fcimb.2022.973563] [Reference Citation Analysis]
22 Piazzesi A, Putignani L. Extremely small and incredibly close: Gut microbes as modulators of inflammation and targets for therapeutic intervention. Front Microbiol 2022;13:958346. [DOI: 10.3389/fmicb.2022.958346] [Reference Citation Analysis]
23 Pinget GV, Tan JK, Ni D, Taitz J, Daien CI, Mielle J, Moore RJ, Stanley D, Simpson S, King NJC, Macia L. Dysbiosis in imiquimod-induced psoriasis alters gut immunity and exacerbates colitis development. Cell Rep 2022;40:111191. [PMID: 35977500 DOI: 10.1016/j.celrep.2022.111191] [Reference Citation Analysis]
24 Kapoor B, Gulati M, Rani P, Gupta R. Psoriasis: Interplay between dysbiosis and host immune system. Autoimmun Rev 2022;21:103169. [PMID: 35964945 DOI: 10.1016/j.autrev.2022.103169] [Reference Citation Analysis]
25 Korochanskaya NV. The microbiome of patients with irritable bowel syndrome: pathophysiology and applied aspects. Medicinskij sovet 2022. [DOI: 10.21518/2079-701x-2022-16-14-107-112] [Reference Citation Analysis]
26 Mao H, Li S, Yin B, Lin X, Guo J, Wang T, Voglmeir J, Liu L. The mechanism of probiotic action of human milk N-glycome towards B. infantis ATCC 15697 and identification of the principal functional components. Food Chemistry 2022;384:132532. [DOI: 10.1016/j.foodchem.2022.132532] [Reference Citation Analysis]
27 Wang J, Zhu X, Li Y, Guo W, Li M, Pan W. Jiedu-Yizhi Formula Alleviates Neuroinflammation in AD Rats by Modulating the Gut Microbiota. Evidence-Based Complementary and Alternative Medicine 2022;2022:1-19. [DOI: 10.1155/2022/4023006] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
28 Mahmud MR, Akter S, Tamanna SK, Mazumder L, Esti IZ, Banerjee S, Akter S, Hasan MR, Acharjee M, Hossain MS, Pirttilä AM. Impact of gut microbiome on skin health: gut-skin axis observed through the lenses of therapeutics and skin diseases. Gut Microbes 2022;14:2096995. [PMID: 35866234 DOI: 10.1080/19490976.2022.2096995] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
29 Buhaș MC, Gavrilaș LI, Candrea R, Cătinean A, Mocan A, Miere D, Tătaru A. Gut Microbiota in Psoriasis. Nutrients 2022;14:2970. [DOI: 10.3390/nu14142970] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
30 Varela-trinidad GU, Domínguez-díaz C, Solórzano-castanedo K, Íñiguez-gutiérrez L, Hernández-flores TDJ, Fafutis-morris M. Probiotics: Protecting Our Health from the Gut. Microorganisms 2022;10:1428. [DOI: 10.3390/microorganisms10071428] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
31 Barros G, Duran P, Vera I, Bermúdez V. Exploring the Links between Obesity and Psoriasis: A Comprehensive Review. IJMS 2022;23:7499. [DOI: 10.3390/ijms23147499] [Reference Citation Analysis]
32 Amieva-balmori M, García-mazcorro J, Martínez-conejo A, Hernández-ramírez G, García-zermeño K, Rodríguez-aguilera O, Aja-cadena M, Barradas-cortés M, Quigley E, Remes-troche J. Fecal bacterial microbiota in constipated patients before and after eight weeks of daily Bifidobacterium infantis 35624 administration. Revista de Gastroenterología de México (English Edition) 2022. [DOI: 10.1016/j.rgmxen.2022.06.014] [Reference Citation Analysis]
33 Wong-Chew RM, de Castro JA, Morelli L, Perez M, Ozen M. Gut immune homeostasis: the immunomodulatory role of Bacillus clausii, from basic to clinical evidence. Expert Rev Clin Immunol 2022;:1-13. [PMID: 35674642 DOI: 10.1080/1744666X.2022.2085559] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
34 Ghelardi E, Abreu Y Abreu AT, Marzet CB, Álvarez Calatayud G, Perez M 3rd, Moschione Castro AP. Current Progress and Future Perspectives on the Use of Bacillus clausii. Microorganisms 2022;10:1246. [PMID: 35744764 DOI: 10.3390/microorganisms10061246] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
35 Judkins TC, Oula ML, Sims SM, Langkamp-Henken B. The effect of a probiotic on gastrointestinal symptoms due to menstruation in healthy adult women on oral contraceptives: randomized, double-blind, placebo-controlled trial protocol. Trials 2022;23:481. [PMID: 35689274 DOI: 10.1186/s13063-022-06410-w] [Reference Citation Analysis]
36 Amieva-balmori M, García-mazcorro J, Martínez-conejo A, Hernández-ramírez G, García-zermeño K, Rodríguez-aguilera O, Aja-cadena M, Cortes-barradas M, Quigley E, Remes-troche J. La microbiota bacteriana fecal en pacientes estreñidos previa y posterior a ocho semanas de administración diaria de Bifidobacterium infantis 35624. Revista de Gastroenterología de México 2022. [DOI: 10.1016/j.rgmx.2022.04.005] [Reference Citation Analysis]
37 Chung M, Bartholomew E, Yeroushalmi S, Hakimi M, Bhutani T, Liao W. Dietary Intervention and Supplements in the Management of Psoriasis: Current Perspectives. PTT 2022;Volume 12:151-176. [DOI: 10.2147/ptt.s328581] [Reference Citation Analysis]
38 Kim JG, Zhang A, Rauseo AM, Goss CW, Mudd PA, O’halloran JA, Wang L. The salivary and nasopharyngeal microbiomes are associated with SARS-CoV-2 infection and disease severity.. [DOI: 10.1101/2022.05.31.494162] [Reference Citation Analysis]
39 Ivashkin VT, Maev IV, Alekseeva OP, Alekseenko SA, Korochanskaya NV, Poluektova EA, Simanenkov VI, Trukhmanov AS, Khlynov IB, Tsukanov VV, Shifrin OS, Lapina TL, Maslennikov RV, Ulyanin AI. Determination of Probiotics Prescription Indications in Patients with Irritable Bowel Syndrome (Materials of the Expert Council and Literature Review). Rossijskij žurnal gastroènterologii, gepatologii, koloproktologii 2022;32:9-18. [DOI: 10.22416/1382-4376-2022-32-2-9-18] [Reference Citation Analysis]
40 Trukhan DI. Disorders of intestinal microbiocenosis: expanding the application of probiotics. Medicinskij sovet 2022. [DOI: 10.21518/2079-701x-2022-16-7-132-143] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
41 Uhlig E, Elli G, Nurminen N, Oscarsson E, Canaviri-Paz P, Burri S, Rohrstock AM, Rahman M, Alsanius B, Molin G, Zeller KS, Håkansson Å. Comparative immunomodulatory effects in mice and in human dendritic cells of five bacterial strains selected for biocontrol of leafy green vegetables. Food Chem Toxicol 2022;:113064. [PMID: 35561874 DOI: 10.1016/j.fct.2022.113064] [Reference Citation Analysis]
42 Thye AY, Bah Y, Law JW, Tan LT, He Y, Wong S, Thurairajasingam S, Chan K, Lee L, Letchumanan V. Gut–Skin Axis: Unravelling the Connection between the Gut Microbiome and Psoriasis. Biomedicines 2022;10:1037. [DOI: 10.3390/biomedicines10051037] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
43 Ghanaatgar M, Taherzadeh S, Ariyanfar S, Razeghi Jahromi S, Martami F, Mahmoudi Gharaei J, Teimourpour A, Shahrivar Z. Probiotic supplement as an adjunctive therapy with Ritalin for treatment of attention-deficit hyperactivity disorder symptoms in children: a double-blind placebo-controlled randomized clinical trial. NFS 2022. [DOI: 10.1108/nfs-12-2021-0388] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
44 Sancar Bozkurt H, Bozkurt H. Single Strain Probiotic Bifidobacteria Approach in Health and Non-Health Fields. Prebiotics and Probiotics - From Food to Health 2022. [DOI: 10.5772/intechopen.99712] [Reference Citation Analysis]
45 Siddique F, Akram K, Saleh Alghamdi E, Arshad Q, Siddique A. The Immunomodulatory Role of Probiotics. Prebiotics and Probiotics - From Food to Health 2022. [DOI: 10.5772/intechopen.98839] [Reference Citation Analysis]
46 Gu W, Zhang L, Han T, Huang H, Chen J. Dynamic Changes in Gut Microbiome of Ulcerative Colitis: Initial Study from Animal Model. JIR 2022;Volume 15:2631-47. [DOI: 10.2147/jir.s358807] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
47 Hu Y, Ye Z, She Y, Li L, Wu M, Qin K, Li Y, He H, Hu Z, Yang M, Lu F, Ye Q. Efficacy and Safety of Probiotics Combined With Traditional Chinese Medicine for Ulcerative Colitis: A Systematic Review and Meta-Analysis. Front Pharmacol 2022;13:844961. [DOI: 10.3389/fphar.2022.844961] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
48 Farsi Y, Tahvildari A, Arbabi M, Vazife F, Sechi LA, Shahidi Bonjar AH, Jamshidi P, Nasiri MJ, Mirsaeidi M. Diagnostic, Prognostic, and Therapeutic Roles of Gut Microbiota in COVID-19: A Comprehensive Systematic Review. Front Cell Infect Microbiol 2022;12:804644. [DOI: 10.3389/fcimb.2022.804644] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
49 Dicks LMT, Endo A. Are fructophilic lactic acid bacteria (FLAB) beneficial to humans? Benef Microbes 2022;:1-10. [PMID: 35144525 DOI: 10.3920/BM2021.0044] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
50 Lucius K. Diet and Nutritional Supplements for Psoriasis. Integrative and Complementary Therapies 2022;28:43-50. [DOI: 10.1089/ict.2022.29007.klu] [Reference Citation Analysis]
51 Liu Y, Wang J, Wu C. Modulation of Gut Microbiota and Immune System by Probiotics, Pre-biotics, and Post-biotics. Front Nutr 2021;8:634897. [PMID: 35047537 DOI: 10.3389/fnut.2021.634897] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
52 Mishra J, Stubbs M, Kuang L, Vara N, Kumar P, Kumar N, Subramanian VS. Inflammatory Bowel Disease Therapeutics: A Focus on Probiotic Engineering. Mediators of Inflammation 2022;2022:1-15. [DOI: 10.1155/2022/9621668] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
53 Mikheenko PV, Akhmedov VA. Chronic skin diseases and pathology of gastrointestinal tract: Is there a connection? Medicinskij alfavit 2022. [DOI: 10.33667/2078-5631-2021-40-21-24] [Reference Citation Analysis]
54 Francis A, Jose AR. Immune-enhancing agents in autoimmune skin diseases – A review. JSSTD 2022;4:19-26. [DOI: 10.25259/jsstd_19_2021] [Reference Citation Analysis]
55 Yadav M. Human Gut Microbiome: A Potential Prospective to Counter Antibiotic-Resistant Pathogens. Comprehensive Gut Microbiota 2022. [DOI: 10.1016/b978-0-12-819265-8.00005-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
56 Tembhre MK, Chawla MK, Berthiaume F, Kumar S. Relationship Between Probiotics and Gut-Skin Axis in Skin Wound Healing: A Recent Update. Probiotic Research in Therapeutics 2022. [DOI: 10.1007/978-981-16-5628-6_8] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
57 Hirayama ALDS, Fonseca DC, Romiti R. Skin Barrier, Microbiome and Psoriasis. Comprehensive Gut Microbiota 2022. [DOI: 10.1016/b978-0-12-819265-8.00033-4] [Reference Citation Analysis]
58 Kadriu H, Yeoman C. The Unseen Minority: Biogeographical Investigations of the Ruminant Gastrointestinal Microbiome Highlight the Importance of Frequently Ignored Anatomical Regions. Gut Microbiota, Immunity, and Health in Production Animals 2022. [DOI: 10.1007/978-3-030-90303-9_9] [Reference Citation Analysis]
59 Gonzalez Maglio D, Friedrich A, Cela E, Paz M, Leoni J. Probiotic Effects on Skin Health: The Case of Photoprotection as a Model of Gut-Skin Dialog. Probiotic Research in Therapeutics 2022. [DOI: 10.1007/978-981-16-5628-6_7] [Reference Citation Analysis]
60 Chugh P, Sood S, Dhar MS. Critical Inspection of the Gut–Brain–Skin Triangle and Its Modulation Through Probiotics. Probiotic Research in Therapeutics 2022. [DOI: 10.1007/978-981-16-6760-2_2] [Reference Citation Analysis]
61 Malaviya A, Krishna KV, Malviya S, Nimisha Das T. Gut-Skin Axis: Role in Health and Disease. Probiotic Research in Therapeutics 2022. [DOI: 10.1007/978-981-16-5628-6_1] [Reference Citation Analysis]
62 Santamaria-babí LF. Microorganisms in Pathogenesis and Management of Psoriasis. Role of Microorganisms in Pathogenesis and Management of Autoimmune Diseases 2022. [DOI: 10.1007/978-981-19-1946-6_8] [Reference Citation Analysis]
63 Giri PS, Bharti A, Kemp EH, Dwivedi MK. Microorganisms in Pathogenesis and Management of Vitiligo. Role of Microorganisms in Pathogenesis and Management of Autoimmune Diseases 2022. [DOI: 10.1007/978-981-19-1946-6_9] [Reference Citation Analysis]
64 Kakade P, Wairkar S, Lohakare S, Shah P, Patravale V. Probiotics for Atopic Dermatitis: An Update. Probiotic Research in Therapeutics 2022. [DOI: 10.1007/978-981-16-5628-6_9] [Reference Citation Analysis]
65 Zeng L, Yu G, Wu Y, Hao W, Chen H. The Effectiveness and Safety of Probiotic Supplements for Psoriasis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials and Preclinical Trials. J Immunol Res 2021;2021:7552546. [PMID: 34938815 DOI: 10.1155/2021/7552546] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
66 Varesi A, Deumer US, Ananth S, Ricevuti G. The Emerging Role of Gut Microbiota in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): Current Evidence and Potential Therapeutic Applications. J Clin Med 2021;10:5077. [PMID: 34768601 DOI: 10.3390/jcm10215077] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
67 Neema S, Sandhu S, Gupta A, Jagadeesan S, Vasudevan B. Unconventional treatment options in psoriasis: A review. Indian J Dermatol Venereol Leprol 2021;:1-7. [PMID: 34623042 DOI: 10.25259/IJDVL_22_2021] [Reference Citation Analysis]
68 Polak K, Jobbágy A, Muszyński T, Wojciechowska K, Frątczak A, Bánvölgyi A, Bergler-Czop B, Kiss N. Microbiome Modulation as a Therapeutic Approach in Chronic Skin Diseases. Biomedicines 2021;9:1436. [PMID: 34680552 DOI: 10.3390/biomedicines9101436] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
69 Tong L, Zhang X, Hao H, Liu Q, Zhou Z, Liang X, Liu T, Gong P, Zhang L, Zhai Z, Hao Y, Yi H. Lactobacillus rhamnosus GG Derived Extracellular Vesicles Modulate Gut Microbiota and Attenuate Inflammatory in DSS-Induced Colitis Mice. Nutrients 2021;13:3319. [PMID: 34684320 DOI: 10.3390/nu13103319] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
70 Pistone D, Meroni G, Panelli S, D'Auria E, Acunzo M, Pasala AR, Zuccotti GV, Bandi C, Drago L. A Journey on the Skin Microbiome: Pitfalls and Opportunities. Int J Mol Sci 2021;22:9846. [PMID: 34576010 DOI: 10.3390/ijms22189846] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
71 Gupta T, Kaur H, Kapila S, Kapila R. Potential probiotic Lacticaseibacillus rhamnosus MTCC-5897 attenuates Escherichia coli induced inflammatory response in intestinal cells. Arch Microbiol 2021;203:5703-13. [PMID: 34476513 DOI: 10.1007/s00203-021-02541-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
72 Kanda N, Hoashi T, Saeki H. The Defect in Regulatory T Cells in Psoriasis and Therapeutic Approaches. J Clin Med 2021;10:3880. [PMID: 34501328 DOI: 10.3390/jcm10173880] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
73 Li M, Zhou X, Stanton C, Ross RP, Zhao J, Zhang H, Yang B, Chen W. Comparative Genomics Analyses Reveal the Differences between B. longum subsp. infantis and B. longum subsp. longum in Carbohydrate Utilisation, CRISPR-Cas Systems and Bacteriocin Operons. Microorganisms 2021;9:1713. [PMID: 34442792 DOI: 10.3390/microorganisms9081713] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
74 Safina DD, Abdulkhakov SR. Coronavirus infection and gut microbiota. Kazan Med J 2021;102:518-527. [DOI: 10.17816/kmj2021-518] [Reference Citation Analysis]
75 Lee HJ, Hong JK, Kim JK, Kim DH, Jang SW, Han SW, Yoon IY. Effects of Probiotic NVP-1704 on Mental Health and Sleep in Healthy Adults: An 8-Week Randomized, Double-Blind, Placebo-Controlled Trial. Nutrients 2021;13:2660. [PMID: 34444820 DOI: 10.3390/nu13082660] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 4.5] [Reference Citation Analysis]
76 Yan D, Gudjonsson JE, Le S, Maverakis E, Plazyo O, Ritchlin C, Scher JU, Singh R, Ward NL, Bell S, Liao W. New Frontiers in Psoriatic Disease Research, Part I: Genetics, Environmental Triggers, Immunology, Pathophysiology, and Precision Medicine. J Invest Dermatol 2021;141:2112-2122.e3. [PMID: 34303522 DOI: 10.1016/j.jid.2021.02.764] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
77 Navarro-López V, Núñez-Delegido E, Ruzafa-Costas B, Sánchez-Pellicer P, Agüera-Santos J, Navarro-Moratalla L. Probiotics in the Therapeutic Arsenal of Dermatologists. Microorganisms 2021;9:1513. [PMID: 34361948 DOI: 10.3390/microorganisms9071513] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
78 Hammond AM, Monir RL, Schoch JJ. The role of the pediatric cutaneous and gut microbiomes in childhood disease: A review. Semin Perinatol 2021;:151452. [PMID: 34272085 DOI: 10.1016/j.semperi.2021.151452] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
79 Deng Y, Fang Z, Cui S, Zhao J, Zhang H, Chen W, Lu W. Evaluation of probiotics for inhibiting hyperproliferation and inflammation relevant to psoriasis in vitro. Journal of Functional Foods 2021;81:104433. [DOI: 10.1016/j.jff.2021.104433] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
80 Zhang F, Ferrero M, Dong N, D'Auria G, Reyes-Prieto M, Herreros-Pomares A, Calabuig-Fariñas S, Duréndez E, Aparisi F, Blasco A, García C, Camps C, Jantus-Lewintre E, Sirera R. Analysis of the Gut Microbiota: An Emerging Source of Biomarkers for Immune Checkpoint Blockade Therapy in Non-Small Cell Lung Cancer. Cancers (Basel) 2021;13:2514. [PMID: 34063829 DOI: 10.3390/cancers13112514] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
81 Meyer J, Roos E, Ris F, Fearnhead N, Davies J. Does dairy product consumption impact the prevalence of inflammatory bowel disease? An ecological cross-sectional analysis. Journal of Functional Foods 2021;80:104446. [DOI: 10.1016/j.jff.2021.104446] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
82 Haddad HW, Mallepalli NR, Scheinuk JE, Bhargava P, Cornett EM, Urits I, Kaye AD. The Role of Nutrient Supplementation in the Management of Chronic Pain in Fibromyalgia: A Narrative Review. Pain Ther 2021. [PMID: 33909266 DOI: 10.1007/s40122-021-00266-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
83 Polak K, Bergler-Czop B, Szczepanek M, Wojciechowska K, Frątczak A, Kiss N. Psoriasis and Gut Microbiome-Current State of Art. Int J Mol Sci 2021;22:4529. [PMID: 33926088 DOI: 10.3390/ijms22094529] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
84 Doney E, Cadoret A, Dion-Albert L, Lebel M, Menard C. Inflammation-driven brain and gut barrier dysfunction in stress and mood disorders. Eur J Neurosci 2021. [PMID: 33876886 DOI: 10.1111/ejn.15239] [Cited by in Crossref: 10] [Cited by in F6Publishing: 14] [Article Influence: 5.0] [Reference Citation Analysis]
85 Marras L, Caputo M, Bisicchia S, Soato M, Bertolino G, Vaccaro S, Inturri R. The Role of Bifidobacteria in Predictive and Preventive Medicine: A Focus on Eczema and Hypercholesterolemia. Microorganisms 2021;9:836. [PMID: 33919907 DOI: 10.3390/microorganisms9040836] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
86 Olejniczak-Staruch I, Ciążyńska M, Sobolewska-Sztychny D, Narbutt J, Skibińska M, Lesiak A. Alterations of the Skin and Gut Microbiome in Psoriasis and Psoriatic Arthritis. Int J Mol Sci 2021;22:3998. [PMID: 33924414 DOI: 10.3390/ijms22083998] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 13.5] [Reference Citation Analysis]
87 Liang Y, Liu M, Pu J, Zhu Z, Gao Z, Zhou Q, Gu Q, Li P. Probiotics and Their Metabolites Ameliorate Inflammatory Bowel Disease: A Critical Review. Infectious Microbes and Diseases 2021;3:4-13. [DOI: 10.1097/im9.0000000000000046] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
88 Singh K, Rao A. Probiotics: A potential immunomodulator in COVID-19 infection management. Nutr Res 2021;87:1-12. [PMID: 33592454 DOI: 10.1016/j.nutres.2020.12.014] [Cited by in Crossref: 41] [Cited by in F6Publishing: 31] [Article Influence: 20.5] [Reference Citation Analysis]
89 Ahlawat S, Kumar P, Mohan H, Goyal S, Sharma KK. Inflammatory bowel disease: tri-directional relationship between microbiota, immune system and intestinal epithelium. Crit Rev Microbiol 2021;47:254-73. [PMID: 33576711 DOI: 10.1080/1040841X.2021.1876631] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 9.5] [Reference Citation Analysis]
90 Plotnikova EY. Unique strain of Bifidobacterium longum and its efficacy in irritable bowel syndrome. Medicinskij sovet 2021. [DOI: 10.21518/2079-701x-2020-21-144-150] [Reference Citation Analysis]
91 Lisitsyna TA, Veltishchev DY, Nasonov EL, Lila AM. Psychiatric aspects of spondyloarthritis. Naučno-praktičeskaâ revmatologiâ 2021;58:716-724. [DOI: 10.47360/1995-4484-2020-716-724] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
92 Ungureanu V. Probiotics and their importance for human health. Medic ro 2021;1:26. [DOI: 10.26416/med.5.1.2021.4587] [Reference Citation Analysis]
93 Lunjani N, Ahearn-Ford S, Dube FS, Hlela C, O'Mahony L. Mechanisms of microbe-immune system dialogue within the skin. Genes Immun 2021;22:276-88. [PMID: 33993202 DOI: 10.1038/s41435-021-00133-9] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
94 Rosenberg E. Microbiomes in Medicine and Agriculture. Microbiomes 2021. [DOI: 10.1007/978-3-030-65317-0_10] [Reference Citation Analysis]
95 Chen L, Li J, Zhu W, Kuang Y, Liu T, Zhang W, Chen X, Peng C. Skin and Gut Microbiome in Psoriasis: Gaining Insight Into the Pathophysiology of It and Finding Novel Therapeutic Strategies. Front Microbiol 2020;11:589726. [PMID: 33384669 DOI: 10.3389/fmicb.2020.589726] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 10.7] [Reference Citation Analysis]
96 Chen Y, Jin Y, Stanton C, Ross RP, Wang Z, Zhao J, Zhang H, Yang B, Chen W. Dose-response efficacy and mechanisms of orally administered CLA-producing Bifidobacterium breve CCFM683 on DSS-induced colitis in mice. Journal of Functional Foods 2020;75:104245. [DOI: 10.1016/j.jff.2020.104245] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
97 Walsh CJ, Healy S, O'Toole PW, Murphy EF, Cotter PD. The probiotic L. casei LC-XCAL™ improves metabolic health in a diet-induced obesity mouse model without altering the microbiome. Gut Microbes 2020;12:1704141. [PMID: 32403964 DOI: 10.1080/19490976.2020.1747330] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
98 Löffler C. Zusammenhänge zwischen Fatigue und Mikronährstoffen sowie Darmmikrobiom. InFo Hämatol Onkol 2020;23:24-31. [DOI: 10.1007/s15004-020-8273-3] [Reference Citation Analysis]
99 Bozkurt HS, Quigley EM. The probiotic Bifidobacterium in the management of Coronavirus: A theoretical basis. Int J Immunopathol Pharmacol 2020;34:2058738420961304. [PMID: 33103512 DOI: 10.1177/2058738420961304] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 8.7] [Reference Citation Analysis]
100 Rigon RB, de Freitas ACP, Bicas JL, Cogo-Müller K, Kurebayashi AK, Magalhães RF, Leonardi GR. Skin microbiota as a therapeutic target for psoriasis treatment: Trends and perspectives. J Cosmet Dermatol 2021;20:1066-72. [PMID: 32998180 DOI: 10.1111/jocd.13752] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
101 Groeger D, Schiavi E, Grant R, Kurnik-Łucka M, Michalovich D, Williamson R, Beinke S, Kiely B, Akdis CA, Hessel EM, Shanahan F, O' Mahony L. Intranasal Bifidobacterium longum protects against viral-induced lung inflammation and injury in a murine model of lethal influenza infection. EBioMedicine 2020;60:102981. [PMID: 32927273 DOI: 10.1016/j.ebiom.2020.102981] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 5.7] [Reference Citation Analysis]
102 Tong J, Satyanarayanan SK, Su H. Nutraceuticals and probiotics in the management of psychiatric and neurological disorders: A focus on microbiota-gut-brain-immune axis. Brain Behav Immun 2020;90:403-19. [PMID: 32889082 DOI: 10.1016/j.bbi.2020.08.027] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
103 Dhillon P, Singh K. Therapeutic applications of probiotics in ulcerative colitis: An updated review. PharmaNutrition 2020;13:100194. [DOI: 10.1016/j.phanu.2020.100194] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 5.3] [Reference Citation Analysis]
104 Darbandi A, Mirshekar M, Shariati A, Moghadam MT, Lohrasbi V, Asadolahi P, Talebi M. The effects of probiotics on reducing the colorectal cancer surgery complications: A periodic review during 2007–2017. Clinical Nutrition 2020;39:2358-67. [DOI: 10.1016/j.clnu.2019.11.008] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 5.3] [Reference Citation Analysis]
105 Rocha-Ramírez LM, Hernández-Ochoa B, Gómez-Manzo S, Marcial-Quino J, Cárdenas-Rodríguez N, Centeno-Leija S, García-Garibay M. Impact of Heat-Killed Lactobacillus casei Strain IMAU60214 on the Immune Function of Macrophages in Malnourished Children. Nutrients 2020;12:E2303. [PMID: 32751919 DOI: 10.3390/nu12082303] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
106 Kanda N, Hoashi T, Saeki H. Nutrition and Psoriasis. Int J Mol Sci 2020;21:E5405. [PMID: 32751360 DOI: 10.3390/ijms21155405] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 10.0] [Reference Citation Analysis]
107 Jadhav P, Jiang Y, Jarr K, Layton C, Ashouri JF, Sinha SR. Efficacy of Dietary Supplements in Inflammatory Bowel Disease and Related Autoimmune Diseases. Nutrients 2020;12:E2156. [PMID: 32698454 DOI: 10.3390/nu12072156] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 5.7] [Reference Citation Analysis]
108 Le ST, Toussi A, Maverakis N, Marusina AI, Barton VR, Merleev AA, Luxardi G, Raychaudhuri SP, Maverakis E. The cutaneous and intestinal microbiome in psoriatic disease. Clin Immunol 2020;218:108537. [PMID: 32679247 DOI: 10.1016/j.clim.2020.108537] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
109 Koper M, Woźniacka A, Robak E. The intestinal microbiota in psoriasis. Postepy Hig Med Dosw 2020;74:236-46. [DOI: 10.5604/01.3001.0014.3052] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
110 Lunjani N, Hlela C, O'Mahony L. Microbiome and skin biology. Curr Opin Allergy Clin Immunol 2019;19:328-33. [PMID: 31107258 DOI: 10.1097/ACI.0000000000000542] [Cited by in Crossref: 39] [Cited by in F6Publishing: 39] [Article Influence: 13.0] [Reference Citation Analysis]
111 Jakubczyk D, Leszczyńska K, Górska S. The Effectiveness of Probiotics in the Treatment of Inflammatory Bowel Disease (IBD)-A Critical Review. Nutrients 2020;12:E1973. [PMID: 32630805 DOI: 10.3390/nu12071973] [Cited by in Crossref: 58] [Cited by in F6Publishing: 67] [Article Influence: 19.3] [Reference Citation Analysis]
112 Hsu DK, Fung MA, Chen H. Role of skin and gut microbiota in the pathogenesis of psoriasis, an inflammatory skin disease. Medicine in Microecology 2020;4:100016. [DOI: 10.1016/j.medmic.2020.100016] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 6.0] [Reference Citation Analysis]
113 Parohan M, Djalali M, Sarraf P, Yaghoubi S, Seraj A, Foroushani AR, Ranji-Burachaloo S, Javanbakht MH. Effect of probiotic supplementation on migraine prophylaxis: a systematic review and meta-analysis of randomized controlled trials. Nutr Neurosci 2020;:1-8. [PMID: 32420827 DOI: 10.1080/1028415X.2020.1764292] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
114 Lu J, Lu L, Yu Y, Baranowski J, Claud EC. Maternal administration of probiotics promotes brain development and protects offspring's brain from postnatal inflammatory insults in C57/BL6J mice. Sci Rep 2020;10:8178. [PMID: 32424168 DOI: 10.1038/s41598-020-65180-0] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
115 Grinnell M, Ogdie A, Wipfler K, Michaud K. Probiotic Use and Psoriatic Arthritis Disease Activity. ACR Open Rheumatol 2020;2:330-4. [PMID: 32386116 DOI: 10.1002/acr2.11143] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
116 Myers B, Brownstone N, Reddy V, Chan S, Thibodeaux Q, Truong A, Bhutani T, Chang HW, Liao W. The gut microbiome in psoriasis and psoriatic arthritis. Best Pract Res Clin Rheumatol 2019;33:101494. [PMID: 32360228 DOI: 10.1016/j.berh.2020.101494] [Cited by in Crossref: 36] [Cited by in F6Publishing: 37] [Article Influence: 12.0] [Reference Citation Analysis]
117 Atabati H, Esmaeili SA, Saburi E, Akhlaghi M, Raoofi A, Rezaei N, Momtazi-Borojeni AA. Probiotics with ameliorating effects on the severity of skin inflammation in psoriasis: Evidence from experimental and clinical studies. J Cell Physiol 2020;235:8925-37. [PMID: 32346892 DOI: 10.1002/jcp.29737] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
118 Yong SJ, Tong T, Chew J, Lim WL. Antidepressive Mechanisms of Probiotics and Their Therapeutic Potential. Front Neurosci 2019;13:1361. [PMID: 32009871 DOI: 10.3389/fnins.2019.01361] [Cited by in Crossref: 59] [Cited by in F6Publishing: 62] [Article Influence: 19.7] [Reference Citation Analysis]
119 Quigley EMM. Nutraceuticals as modulators of gut microbiota: Role in therapy. Br J Pharmacol 2020;177:1351-62. [PMID: 31659751 DOI: 10.1111/bph.14902] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 4.3] [Reference Citation Analysis]
120 El-ansary A, Bhat RS. Targeting gut microbiota as a possible therapeutic intervention in autism. Autism 360° 2020. [DOI: 10.1016/b978-0-12-818466-0.00017-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
121 Alesa DI, Alshamrani HM, Alzahrani YA, Alamssi DN, Alzahrani NS, Almohammadi ME. The role of gut microbiome in the pathogenesis of psoriasis and the therapeutic effects of probiotics. J Family Med Prim Care 2019;8:3496-503. [PMID: 31803643 DOI: 10.4103/jfmpc.jfmpc_709_19] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 7.0] [Reference Citation Analysis]
122 Newman TM, Vitolins MZ, Cook KL. From the Table to the Tumor: The Role of Mediterranean and Western Dietary Patterns in Shifting Microbial-Mediated Signaling to Impact Breast Cancer Risk. Nutrients 2019;11:E2565. [PMID: 31652909 DOI: 10.3390/nu11112565] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 5.5] [Reference Citation Analysis]
123 Picó-Monllor JA, Mingot-Ascencao JM. Search and Selection of Probiotics That Improve Mucositis Symptoms in Oncologic Patients. A Systematic Review. Nutrients 2019;11:E2322. [PMID: 31581434 DOI: 10.3390/nu11102322] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 3.8] [Reference Citation Analysis]
124 Terziroli Beretta-Piccoli B, Mieli-Vergani G, Vergani D, Vierling JM, Adams D, Alpini G, Banales JM, Beuers U, Björnsson E, Bowlus C, Carbone M, Chazouillères O, Dalekos G, De Gottardi A, Harada K, Hirschfield G, Invernizzi P, Jones D, Krawitt E, Lanzavecchia A, Lian ZX, Ma X, Manns M, Mavilio D, Quigley EM, Sallusto F, Shimoda S, Strazzabosco M, Swain M, Tanaka A, Trauner M, Tsuneyama K, Zigmond E, Gershwin ME. The challenges of primary biliary cholangitis: What is new and what needs to be done. J Autoimmun 2019;105:102328. [PMID: 31548157 DOI: 10.1016/j.jaut.2019.102328] [Cited by in Crossref: 55] [Cited by in F6Publishing: 57] [Article Influence: 13.8] [Reference Citation Analysis]
125 Li MY, Zhang ZH, Wang Z, Zuo HX, Wang JY, Xing Y, Jin CH, Xu GH, Piao LX, Ma J, Jin X. Convallatoxin protects against dextran sulfate sodium-induced experimental colitis in mice by inhibiting NF-κB signaling through activation of PPARγ. Pharmacological Research 2019;147:104355. [DOI: 10.1016/j.phrs.2019.104355] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
126 Sireswar S, Ghosh I, Dey G. First and second generation probiotic therapeutics for Inflammatory Bowel Disease. PharmaNutrition 2019;9:100159. [DOI: 10.1016/j.phanu.2019.100159] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.8] [Reference Citation Analysis]
127 Szántó M, Dózsa A, Antal D, Szabó K, Kemény L, Bai P. Targeting the gut-skin axis-Probiotics as new tools for skin disorder management? Exp Dermatol 2019;28:1210-8. [PMID: 31386766 DOI: 10.1111/exd.14016] [Cited by in Crossref: 53] [Cited by in F6Publishing: 55] [Article Influence: 13.3] [Reference Citation Analysis]
128 Strawbridge R, Sartor ML, Scott F, Cleare AJ. Inflammatory proteins are altered in chronic fatigue syndrome-A systematic review and meta-analysis. Neurosci Biobehav Rev 2019;107:69-83. [PMID: 31465778 DOI: 10.1016/j.neubiorev.2019.08.011] [Cited by in Crossref: 26] [Cited by in F6Publishing: 20] [Article Influence: 6.5] [Reference Citation Analysis]
129 Catinean A, Neag MA, Mitre AO, Bocsan CI, Buzoianu AD. Microbiota and Immune-Mediated Skin Diseases-An Overview. Microorganisms 2019;7:E279. [PMID: 31438634 DOI: 10.3390/microorganisms7090279] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 3.8] [Reference Citation Analysis]
130 Haahtela T. A biodiversity hypothesis. Allergy 2019;74:1445-56. [PMID: 30835837 DOI: 10.1111/all.13763] [Cited by in Crossref: 47] [Cited by in F6Publishing: 69] [Article Influence: 11.8] [Reference Citation Analysis]
131 Traina G. Mast Cells in Gut and Brain and Their Potential Role as an Emerging Therapeutic Target for Neural Diseases. Front Cell Neurosci 2019;13:345. [PMID: 31417365 DOI: 10.3389/fncel.2019.00345] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 7.0] [Reference Citation Analysis]
132 Yu Y, Dunaway S, Champer J, Kim J, Alikhan A. Changing our microbiome: probiotics in dermatology. Br J Dermatol 2020;182:39-46. [PMID: 31049923 DOI: 10.1111/bjd.18088] [Cited by in Crossref: 32] [Cited by in F6Publishing: 43] [Article Influence: 8.0] [Reference Citation Analysis]
133 Brown BP, Jaspan HB. Compositional analyses reveal correlations between taxon-level gut bacterial abundance and peripheral T cell marker expression in African infants. Gut Microbes 2020;11:237-44. [PMID: 31347944 DOI: 10.1080/19490976.2019.1643673] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
134 Iwauchi M, Horigome A, Ishikawa K, Mikuni A, Nakano M, Xiao JZ, Odamaki T, Hironaka S. Relationship between oral and gut microbiota in elderly people. Immun Inflamm Dis 2019;7:229-36. [PMID: 31305026 DOI: 10.1002/iid3.266] [Cited by in Crossref: 22] [Cited by in F6Publishing: 25] [Article Influence: 5.5] [Reference Citation Analysis]
135 Groven N, Fors EA, Reitan SK. Patients with Fibromyalgia and Chronic Fatigue Syndrome show increased hsCRP compared to healthy controls. Brain Behav Immun 2019;81:172-7. [PMID: 31176728 DOI: 10.1016/j.bbi.2019.06.010] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 6.0] [Reference Citation Analysis]
136 Achi SC, Talahalli RR, Halami PM. Prophylactic effects of probiotic Bifidobacterium spp. in the resolution of inflammation in arthritic rats. Appl Microbiol Biotechnol 2019;103:6287-96. [PMID: 31168650 DOI: 10.1007/s00253-019-09864-2] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
137 Lombardi VR, Carrera I, Corzo L, Cacabelos R. Role of bioactive lipofishins in prevention of inflammation and colon cancer. Seminars in Cancer Biology 2019;56:175-84. [DOI: 10.1016/j.semcancer.2017.11.012] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
138 Roman P, Abalo R, Marco EM, Cardona D. Probiotics in digestive, emotional, and pain-related disorders. Behav Pharmacol 2018;29:103-19. [PMID: 29521671 DOI: 10.1097/FBP.0000000000000385] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
139 Piqué N, Berlanga M, Miñana-Galbis D. Health Benefits of Heat-Killed (Tyndallized) Probiotics: An Overview. Int J Mol Sci 2019;20:E2534. [PMID: 31126033 DOI: 10.3390/ijms20102534] [Cited by in Crossref: 181] [Cited by in F6Publishing: 192] [Article Influence: 45.3] [Reference Citation Analysis]
140 Lolou V, Panayiotidis MI. Functional Role of Probiotics and Prebiotics on Skin Health and Disease. Fermentation 2019;5:41. [DOI: 10.3390/fermentation5020041] [Cited by in Crossref: 36] [Cited by in F6Publishing: 39] [Article Influence: 9.0] [Reference Citation Analysis]
141 Kazemi A, Soltani S, Ghorabi S, Keshtkar A, Daneshzad E, Nasri F, Mazloomi SM. Effect of probiotic and synbiotic supplementation on inflammatory markers in health and disease status: A systematic review and meta-analysis of clinical trials.Clin Nutr. 2020;39:789-819. [PMID: 31060892 DOI: 10.1016/j.clnu.2019.04.004] [Cited by in Crossref: 49] [Cited by in F6Publishing: 53] [Article Influence: 12.3] [Reference Citation Analysis]
142 Kiousi DE, Karapetsas A, Karolidou K, Panayiotidis MI, Pappa A, Galanis A. Probiotics in Extraintestinal Diseases: Current Trends and New Directions. Nutrients 2019;11:E788. [PMID: 30959761 DOI: 10.3390/nu11040788] [Cited by in Crossref: 39] [Cited by in F6Publishing: 39] [Article Influence: 9.8] [Reference Citation Analysis]
143 Parada Venegas D, De la Fuente MK, Landskron G, González MJ, Quera R, Dijkstra G, Harmsen HJM, Faber KN, Hermoso MA. Short Chain Fatty Acids (SCFAs)-Mediated Gut Epithelial and Immune Regulation and Its Relevance for Inflammatory Bowel Diseases. Front Immunol 2019;10:277. [PMID: 30915065 DOI: 10.3389/fimmu.2019.00277] [Cited by in Crossref: 970] [Cited by in F6Publishing: 1077] [Article Influence: 242.5] [Reference Citation Analysis]
144 Milajerdi A, Mousavi SM, Sadeghi A, Salari-Moghaddam A, Parohan M, Larijani B, Esmaillzadeh A. The effect of probiotics on inflammatory biomarkers: a meta-analysis of randomized clinical trials. Eur J Nutr 2020;59:633-49. [PMID: 30854594 DOI: 10.1007/s00394-019-01931-8] [Cited by in Crossref: 36] [Cited by in F6Publishing: 34] [Article Influence: 9.0] [Reference Citation Analysis]
145 Maia LP, Levi YLDAS, do Prado RL, Santinoni CDS, Marsicano JA. Effects of probiotic therapy on serum inflammatory markers: A systematic review and meta-analysis. Journal of Functional Foods 2019;54:466-78. [DOI: 10.1016/j.jff.2019.01.051] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
146 Astó E, Méndez I, Audivert S, Farran-Codina A, Espadaler J. The Efficacy of Probiotics, Prebiotic Inulin-Type Fructans, and Synbiotics in Human Ulcerative Colitis: A Systematic Review and Meta-Analysis.Nutrients. 2019;11. [PMID: 30704039 DOI: 10.3390/nu11020293] [Cited by in Crossref: 56] [Cited by in F6Publishing: 57] [Article Influence: 14.0] [Reference Citation Analysis]
147 Inglis JE, Lin PJ, Kerns SL, Kleckner IR, Kleckner AS, Castillo DA, Mustian KM, Peppone LJ. Nutritional Interventions for Treating Cancer-Related Fatigue: A Qualitative Review. Nutr Cancer 2019;71:21-40. [PMID: 30688088 DOI: 10.1080/01635581.2018.1513046] [Cited by in Crossref: 38] [Cited by in F6Publishing: 27] [Article Influence: 9.5] [Reference Citation Analysis]
148 Liu J, Johnson R, Dillon S, Kroehl M, Frank DN, Tuncil YE, Zhang X, Ir D, Robertson CE, Seifert S, Higgins J, Hamaker B, Wilson CC, Erlandson KM. Among older adults, age-related changes in the stool microbiome differ by HIV-1 serostatus. EBioMedicine 2019;40:583-94. [PMID: 30685386 DOI: 10.1016/j.ebiom.2019.01.033] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
149 Trukhan DI, Goloshubina VV, Ivanova DS. Actual issues of diagnosis and treatment of irritable bowel syndrome. Med sov 2019. [DOI: 10.21518/2079-701x-2018-21-110-116] [Reference Citation Analysis]
150 Martami F, Togha M, Seifishahpar M, Ghorbani Z, Ansari H, Karimi T, Jahromi SR. The effects of a multispecies probiotic supplement on inflammatory markers and episodic and chronic migraine characteristics: A randomized double-blind controlled trial. Cephalalgia 2019;39:841-53. [PMID: 30621517 DOI: 10.1177/0333102418820102] [Cited by in Crossref: 33] [Cited by in F6Publishing: 34] [Article Influence: 8.3] [Reference Citation Analysis]
151 Lunjani N, O’mahony L. Critical Entry Points—Microbiome. Implementing Precision Medicine in Best Practices of Chronic Airway Diseases 2019. [DOI: 10.1016/b978-0-12-813471-9.00011-6] [Reference Citation Analysis]
152 Plaza-diaz J, Ruiz-ojeda F, Arias-tellez M, Solis-urra P, Saez-lara M, Gil A. Use of Probiotics in Inflammatory Bowel Disease. Microbiome and Metabolome in Diagnosis, Therapy, and other Strategic Applications 2019. [DOI: 10.1016/b978-0-12-815249-2.00015-4] [Reference Citation Analysis]
153 Quigley EMM. Prebiotics and Probiotics in Digestive Health. Clin Gastroenterol Hepatol 2019;17:333-44. [PMID: 30267869 DOI: 10.1016/j.cgh.2018.09.028] [Cited by in Crossref: 141] [Cited by in F6Publishing: 141] [Article Influence: 35.3] [Reference Citation Analysis]
154 Satapathy P, Khan K, Devi AT, Patil AG, Govindaraju AM, Gopal S, Prasad MNN, More VS, Kakarla RR, Raghu AV, Hudeda S, More SS, Zameer F. Synthetic gutomics: Deciphering the microbial code for futuristic diagnosis and personalized medicine. Methods in Microbiology 2019. [DOI: 10.1016/bs.mim.2019.02.001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
155 Vodnar DC, Călinoiu LF, Mitrea L, Precup G, Bindea M, Păcurar AM, Szabo K, Ştefănescu BE. A New Generation of Probiotic Functional Beverages Using Bioactive Compounds From Agro-Industrial Waste. Functional and Medicinal Beverages 2019. [DOI: 10.1016/b978-0-12-816397-9.00015-7] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
156 Stefani S, Ngatidjan S, Paotiana M, Sitompul KA, Abdullah M, Sulistianingsih DP, Shankar AH, Agustina R. Dietary quality of predominantly traditional diets is associated with blood glucose profiles, but not with total fecal Bifidobacterium in Indonesian women. PLoS One 2018;13:e0208815. [PMID: 30576336 DOI: 10.1371/journal.pone.0208815] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
157 Lunjani N, Satitsuksanoa P, Lukasik Z, Sokolowska M, Eiwegger T, O'Mahony L. Recent developments and highlights in mechanisms of allergic diseases: Microbiome. Allergy 2018;73:2314-27. [PMID: 30325537 DOI: 10.1111/all.13634] [Cited by in Crossref: 71] [Cited by in F6Publishing: 73] [Article Influence: 14.2] [Reference Citation Analysis]
158 Zakharenko SM. Probiotics: a new or an old concept? Med sov 2018. [DOI: 10.21518/2079-701x-2018-14-56-60] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
159 Carbuhn AF, Reynolds SM, Campbell CW, Bradford LA, Deckert JA, Kreutzer A, Fry AC. Effects of Probiotic (Bifidobacterium longum 35624) Supplementation on Exercise Performance, Immune Modulation, and Cognitive Outlook in Division I Female Swimmers. Sports (Basel) 2018;6:E116. [PMID: 30308984 DOI: 10.3390/sports6040116] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 4.4] [Reference Citation Analysis]
160 Balato A, Cacciapuoti S, Di Caprio R, Marasca C, Masarà A, Raimondo A, Fabbrocini G. Human Microbiome: Composition and Role in Inflammatory Skin Diseases. Arch Immunol Ther Exp (Warsz) 2019;67:1-18. [PMID: 30302512 DOI: 10.1007/s00005-018-0528-4] [Cited by in Crossref: 41] [Cited by in F6Publishing: 44] [Article Influence: 8.2] [Reference Citation Analysis]
161 Wang T, Yu L, Xu C, Pan K, Mo M, Duan M, Zhang Y, Xiong H. Chronic fatigue syndrome patients have alterations in their oral microbiome composition and function. PLoS One 2018;13:e0203503. [PMID: 30204780 DOI: 10.1371/journal.pone.0203503] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
162 Westfall S, Lomis N, Prakash S. A polyphenol-rich prebiotic in combination with a novel probiotic formulation alleviates markers of obesity and diabetes in Drosophila. Journal of Functional Foods 2018;48:374-86. [DOI: 10.1016/j.jff.2018.07.012] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
163 Lv Q, Wang K, Qiao SM, Dai Y, Wei ZF. Norisoboldine, a natural aryl hydrocarbon receptor agonist, alleviates TNBS-induced colitis in mice, by inhibiting the activation of NLRP3 inflammasome. Chin J Nat Med 2018;16:161-74. [PMID: 29576052 DOI: 10.1016/S1875-5364(18)30044-X] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
164 Giron F, Quigley EMM. Pharmabiotic Manipulation of the Microbiota in Gastrointestinal Disorders: A Clinical Perspective. J Neurogastroenterol Motil 2018;24:355-66. [PMID: 29684976 DOI: 10.5056/jnm18004] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
165 Salem I, Ramser A, Isham N, Ghannoum MA. The Gut Microbiome as a Major Regulator of the Gut-Skin Axis. Front Microbiol 2018;9:1459. [PMID: 30042740 DOI: 10.3389/fmicb.2018.01459] [Cited by in Crossref: 223] [Cited by in F6Publishing: 229] [Article Influence: 44.6] [Reference Citation Analysis]
166 Schiavi E, Plattner S, Rodriguez-Perez N, Barcik W, Frei R, Ferstl R, Kurnik-Lucka M, Groeger D, Grant R, Roper J, Altmann F, van Sinderen D, Akdis CA, O'Mahony L. Exopolysaccharide from Bifidobacterium longum subsp. longum 35624™ modulates murine allergic airway responses. Benef Microbes 2018;9:761-73. [PMID: 29726281 DOI: 10.3920/BM2017.0180] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 3.8] [Reference Citation Analysis]
167 Karbaschian Z, Mokhtari Z, Pazouki A, Kabir A, Hedayati M, Moghadam SS, Mirmiran P, Hekmatdoost A. Probiotic Supplementation in Morbid Obese Patients Undergoing One Anastomosis Gastric Bypass-Mini Gastric Bypass (OAGB-MGB) Surgery: a Randomized, Double-Blind, Placebo-Controlled, Clinical Trial. OBES SURG 2018;28:2874-85. [DOI: 10.1007/s11695-018-3280-2] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 4.8] [Reference Citation Analysis]
168 Binda C, Lopetuso LR, Rizzatti G, Gibiino G, Cennamo V, Gasbarrini A. Actinobacteria: A relevant minority for the maintenance of gut homeostasis. Dig Liver Dis 2018;50:421-8. [PMID: 29567414 DOI: 10.1016/j.dld.2018.02.012] [Cited by in Crossref: 221] [Cited by in F6Publishing: 218] [Article Influence: 44.2] [Reference Citation Analysis]
169 Roman P, Carrillo-Trabalón F, Sánchez-Labraca N, Cañadas F, Estévez AF, Cardona D. Are probiotic treatments useful on fibromyalgia syndrome or chronic fatigue syndrome patients? A systematic review. Benef Microbes 2018;9:603-11. [PMID: 29695180 DOI: 10.3920/BM2017.0125] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 4.0] [Reference Citation Analysis]
170 Jena PK, Sheng L, Nagar N, Wu C, Barile D, Mills DA, Wan YY. Synbiotics Bifidobacterium infantis and milk oligosaccharides are effective in reversing cancer-prone nonalcoholic steatohepatitis using western diet-fed FXR knockout mouse models. J Nutr Biochem 2018;57:246-54. [PMID: 29800811 DOI: 10.1016/j.jnutbio.2018.04.007] [Cited by in Crossref: 33] [Cited by in F6Publishing: 29] [Article Influence: 6.6] [Reference Citation Analysis]
171 Yahfoufi N, Mallet J, Graham E, Matar C. Role of probiotics and prebiotics in immunomodulation. Current Opinion in Food Science 2018;20:82-91. [DOI: 10.1016/j.cofs.2018.04.006] [Cited by in Crossref: 55] [Cited by in F6Publishing: 24] [Article Influence: 11.0] [Reference Citation Analysis]
172 Cavalcanti Neto MP, Aquino JDS, Romão da Silva LDF, de Oliveira Silva R, Guimarães KSDL, de Oliveira Y, de Souza EL, Magnani M, Vidal H, de Brito Alves JL. Gut microbiota and probiotics intervention: A potential therapeutic target for management of cardiometabolic disorders and chronic kidney disease? Pharmacological Research 2018;130:152-63. [DOI: 10.1016/j.phrs.2018.01.020] [Cited by in Crossref: 50] [Cited by in F6Publishing: 51] [Article Influence: 10.0] [Reference Citation Analysis]
173 Langan EA, Griffiths CEM, Solbach W, Knobloch JK, Zillikens D, Thaçi D. The role of the microbiome in psoriasis: moving from disease description to treatment selection? Br J Dermatol 2018;178:1020-7. [PMID: 29071712 DOI: 10.1111/bjd.16081] [Cited by in Crossref: 42] [Cited by in F6Publishing: 43] [Article Influence: 8.4] [Reference Citation Analysis]
174 Corbitt M, Campagnolo N, Staines D, Marshall-gradisnik S. A Systematic Review of Probiotic Interventions for Gastrointestinal Symptoms and Irritable Bowel Syndrome in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (CFS/ME). Probiotics & Antimicro Prot 2018;10:466-77. [DOI: 10.1007/s12602-018-9397-8] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 3.8] [Reference Citation Analysis]
175 Wallis A, Ball M, Butt H, Lewis DP, McKechnie S, Paull P, Jaa-Kwee A, Bruck D. Open-label pilot for treatment targeting gut dysbiosis in myalgic encephalomyelitis/chronic fatigue syndrome: neuropsychological symptoms and sex comparisons. J Transl Med 2018;16:24. [PMID: 29409505 DOI: 10.1186/s12967-018-1392-z] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
176 Dicks L, Geldenhuys J, Mikkelsen L, Brandsborg E, Marcotte H. Our gut microbiota: a long walk to homeostasis. Beneficial Microbes 2018;9:3-20. [DOI: 10.3920/bm2017.0066] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 5.8] [Reference Citation Analysis]
177 Wang K, Li YF, Lv Q, Li XM, Dai Y, Wei ZF. Bergenin, Acting as an Agonist of PPARγ, Ameliorates Experimental Colitis in Mice through Improving Expression of SIRT1, and Therefore Inhibiting NF-κB-Mediated Macrophage Activation. Front Pharmacol 2017;8:981. [PMID: 29375382 DOI: 10.3389/fphar.2017.00981] [Cited by in Crossref: 43] [Cited by in F6Publishing: 47] [Article Influence: 8.6] [Reference Citation Analysis]
178 Clemente JC, Manasson J, Scher JU. The role of the gut microbiome in systemic inflammatory disease. BMJ. 2018;360:j5145. [PMID: 29311119 DOI: 10.1136/bmj.j5145] [Cited by in Crossref: 246] [Cited by in F6Publishing: 247] [Article Influence: 49.2] [Reference Citation Analysis]
179 Sokolowska M, Frei R, Lunjani N, Akdis CA, O'Mahony L. Microbiome and asthma. Asthma Res Pract 2018;4:1. [PMID: 29318023 DOI: 10.1186/s40733-017-0037-y] [Cited by in Crossref: 82] [Cited by in F6Publishing: 86] [Article Influence: 16.4] [Reference Citation Analysis]
180 Hidalgo-cantabrana C, Delgado S, Ruiz L, Ruas-madiedo P, Sánchez B, Margolles A. Bifidobacteria and Their Health-Promoting Effects. Bugs as Drugs 2018. [DOI: 10.1128/9781555819705.ch3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
181 Riedel CU. Clinical Significance of Bifidobacteria. The Bifidobacteria and Related Organisms 2018. [DOI: 10.1016/b978-0-12-805060-6.00013-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
182 Reale M, Falasca K. Probiotics and Anti-inflammatory Processes in HIV Infection. Immunity and Inflammation in Health and Disease 2018. [DOI: 10.1016/b978-0-12-805417-8.00024-x] [Reference Citation Analysis]
183 Ghosh AR. Probiotics in the Rescue of Gut Inflammation. Therapeutic, Probiotic, and Unconventional Foods 2018. [DOI: 10.1016/b978-0-12-814625-5.00006-6] [Cited by in Crossref: 2] [Article Influence: 0.4] [Reference Citation Analysis]
184 Ruiz L, Delgado S, Ruas-Madiedo P, Sánchez B, Margolles A. Bifidobacteria and Their Molecular Communication with the Immune System. Front Microbiol 2017;8:2345. [PMID: 29255450 DOI: 10.3389/fmicb.2017.02345] [Cited by in Crossref: 142] [Cited by in F6Publishing: 151] [Article Influence: 23.7] [Reference Citation Analysis]
185 Bravo D, Landete JM. Genetic engineering as a powerful tool to improve probiotic strains. Biotechnology and Genetic Engineering Reviews 2017;33:173-89. [DOI: 10.1080/02648725.2017.1408257] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
186 Notay M, Foolad N, Vaughn AR, Sivamani RK. Probiotics, Prebiotics, and Synbiotics for the Treatment and Prevention of Adult Dermatological Diseases. Am J Clin Dermatol 2017;18:721-32. [PMID: 28681230 DOI: 10.1007/s40257-017-0300-2] [Cited by in Crossref: 37] [Cited by in F6Publishing: 23] [Article Influence: 6.2] [Reference Citation Analysis]
187 Abraham BP, Quigley EMM. Probiotics in Inflammatory Bowel Disease. Gastroenterol Clin North Am 2017;46:769-82. [PMID: 29173520 DOI: 10.1016/j.gtc.2017.08.003] [Cited by in Crossref: 102] [Cited by in F6Publishing: 98] [Article Influence: 17.0] [Reference Citation Analysis]
188 O'Neill I, Schofield Z, Hall LJ. Exploring the role of the microbiota member Bifidobacterium in modulating immune-linked diseases. Emerg Top Life Sci 2017;1:333-49. [PMID: 33525778 DOI: 10.1042/ETLS20170058] [Cited by in Crossref: 53] [Cited by in F6Publishing: 56] [Article Influence: 8.8] [Reference Citation Analysis]
189 Vaughn AR, Notay M, Clark AK, Sivamani RK. Skin-gut axis: The relationship between intestinal bacteria and skin health. World J Dermatol 2017; 6(4): 52-58 [DOI: 10.5314/wjd.v6.i4.52] [Cited by in CrossRef: 24] [Cited by in F6Publishing: 24] [Article Influence: 4.0] [Reference Citation Analysis]
190 Skrypnik K, Suliburska J. Association between the gut microbiota and mineral metabolism. J Sci Food Agric 2018;98:2449-60. [PMID: 28991359 DOI: 10.1002/jsfa.8724] [Cited by in Crossref: 86] [Cited by in F6Publishing: 88] [Article Influence: 14.3] [Reference Citation Analysis]
191 Barcik W, Wawrzyniak M, Akdis CA, O’mahony L. Immune regulation by histamine and histamine-secreting bacteria. Current Opinion in Immunology 2017;48:108-13. [DOI: 10.1016/j.coi.2017.08.011] [Cited by in Crossref: 57] [Cited by in F6Publishing: 60] [Article Influence: 9.5] [Reference Citation Analysis]
192 Hidalgo-Cantabrana C, Delgado S, Ruiz L, Ruas-Madiedo P, Sánchez B, Margolles A. Bifidobacteria and Their Health-Promoting Effects. Microbiol Spectr 2017;5. [PMID: 28643627 DOI: 10.1128/microbiolspec.BAD-0010-2016] [Cited by in Crossref: 128] [Cited by in F6Publishing: 144] [Article Influence: 21.3] [Reference Citation Analysis]
193 Reid G, Abrahamsson T, Bailey M, Bindels L, Bubnov R, Ganguli K, Martoni C, O’neill C, Savignac H, Stanton C, Ship N, Surette M, Tuohy K, van Hemert S. How do probiotics and prebiotics function at distant sites? Beneficial Microbes 2017;8:521-33. [DOI: 10.3920/bm2016.0222] [Cited by in Crossref: 50] [Cited by in F6Publishing: 53] [Article Influence: 8.3] [Reference Citation Analysis]
194 Scheibenbogen C, Freitag H, Blanco J, Capelli E, Lacerda E, Authier J, Meeus M, Castro Marrero J, Nora-Krukle Z, Oltra E, Strand EB, Shikova E, Sekulic S, Murovska M. The European ME/CFS Biomarker Landscape project: an initiative of the European network EUROMENE. J Transl Med 2017;15:162. [PMID: 28747192 DOI: 10.1186/s12967-017-1263-z] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 4.5] [Reference Citation Analysis]
195 Ponziani FR, Zocco MA, D’Aversa F, Pompili M, Gasbarrini A. Eubiotic properties of rifaximin: Disruption of the traditional concepts in gut microbiota modulation. World J Gastroenterol 2017; 23(25): 4491-4499 [PMID: 28740337 DOI: 10.3748/wjg.v23.i25.4491] [Cited by in CrossRef: 78] [Cited by in F6Publishing: 81] [Article Influence: 13.0] [Reference Citation Analysis]
196 Lyseng-williamson KA. Bifidobacterium infantis 35624 as a probiotic dietary supplement: a profile of its use. Drugs Ther Perspect 2017;33:368-74. [DOI: 10.1007/s40267-017-0423-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
197 Wallis A, Ball M, McKechnie S, Butt H, Lewis DP, Bruck D. Examining clinical similarities between myalgic encephalomyelitis/chronic fatigue syndrome and D-lactic acidosis: a systematic review. J Transl Med 2017;15:129. [PMID: 28592308 DOI: 10.1186/s12967-017-1229-1] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
198 Kelly DL, Lyon DE, Yoon SL, Horgas AL. The Microbiome and Cancer: Implications for Oncology Nursing Science. Cancer Nurs 2016;39:E56-62. [PMID: 26110573 DOI: 10.1097/NCC.0000000000000286] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 2.8] [Reference Citation Analysis]
199 Plaza-Díaz J, Ruiz-Ojeda FJ, Vilchez-Padial LM, Gil A. Evidence of the Anti-Inflammatory Effects of Probiotics and Synbiotics in Intestinal Chronic Diseases. Nutrients 2017;9:E555. [PMID: 28555037 DOI: 10.3390/nu9060555] [Cited by in Crossref: 199] [Cited by in F6Publishing: 209] [Article Influence: 33.2] [Reference Citation Analysis]
200 Vogelaar L, de Haar C, Aerts BR, Peppelenbosch MP, Timman R, Hanssen BE, van der Woude CJ. Fatigue in patients with inflammatory bowel disease is associated with distinct differences in immune parameters. Clin Exp Gastroenterol. 2017;10:83-90. [PMID: 28496351 DOI: 10.2147/ceg.s123942] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 3.8] [Reference Citation Analysis]
201 Yan D, Issa N, Afifi L, Jeon C, Chang HW, Liao W. The Role of the Skin and Gut Microbiome in Psoriatic Disease. Curr Dermatol Rep 2017;6:94-103. [PMID: 28804689 DOI: 10.1007/s13671-017-0178-5] [Cited by in Crossref: 65] [Cited by in F6Publishing: 51] [Article Influence: 10.8] [Reference Citation Analysis]
202 Bogner J. Können Sie Probiotika empfehlen? MMW - Fortschritte der Medizin 2017;159:49-52. [DOI: 10.1007/s15006-017-9339-5] [Reference Citation Analysis]
203 Smolinska S, Groeger D, O'Mahony L. Biology of the Microbiome 1: Interactions with the Host Immune Response. Gastroenterol Clin North Am 2017;46:19-35. [PMID: 28164850 DOI: 10.1016/j.gtc.2016.09.004] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 4.0] [Reference Citation Analysis]
204 Shigemori S, Shimosato T. Applications of Genetically Modified Immunobiotics with High Immunoregulatory Capacity for Treatment of Inflammatory Bowel Diseases. Front Immunol 2017;8:22. [PMID: 28179904 DOI: 10.3389/fimmu.2017.00022] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 4.8] [Reference Citation Analysis]
205 Quigley E. Bifidobacterium longum spp. infantis. The Microbiota in Gastrointestinal Pathophysiology 2017. [DOI: 10.1016/b978-0-12-804024-9.00017-3] [Reference Citation Analysis]
206 Bravo-Blas A, Wessel H, Milling S. Microbiota and arthritis: correlations or cause? Curr Opin Rheumatol 2016;28:161-7. [PMID: 26814405 DOI: 10.1097/BOR.0000000000000261] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.9] [Reference Citation Analysis]
207 Schiavi E, Gleinser M, Molloy E, Groeger D, Frei R, Ferstl R, Rodriguez-Perez N, Ziegler M, Grant R, Moriarty TF, Plattner S, Healy S, O'Connell Motherway M, Akdis CA, Roper J, Altmann F, van Sinderen D, O'Mahony L. The Surface-Associated Exopolysaccharide of Bifidobacterium longum 35624 Plays an Essential Role in Dampening Host Proinflammatory Responses and Repressing Local TH17 Responses. Appl Environ Microbiol 2016;82:7185-96. [PMID: 27736791 DOI: 10.1128/AEM.02238-16] [Cited by in Crossref: 91] [Cited by in F6Publishing: 91] [Article Influence: 13.0] [Reference Citation Analysis]
208 Wang H, Lee IS, Braun C, Enck P. Effect of Probiotics on Central Nervous System Functions in Animals and Humans: A Systematic Review. J Neurogastroenterol Motil 2016;22:589-605. [PMID: 27413138 DOI: 10.5056/jnm16018] [Cited by in Crossref: 178] [Cited by in F6Publishing: 188] [Article Influence: 25.4] [Reference Citation Analysis]
209 Barcik W, Untersmayr E, Pali-Schöll I, O'Mahony L, Frei R. Influence of microbiome and diet on immune responses in food allergy models. Drug Discov Today Dis Models 2015;17-18:71-80. [PMID: 29967644 DOI: 10.1016/j.ddmod.2016.06.003] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
210 Johnson CH, Spilker ME, Goetz L, Peterson SN, Siuzdak G. Metabolite and Microbiome Interplay in Cancer Immunotherapy. Cancer Res 2016;76:6146-52. [PMID: 27729325 DOI: 10.1158/0008-5472.CAN-16-0309] [Cited by in Crossref: 60] [Cited by in F6Publishing: 65] [Article Influence: 8.6] [Reference Citation Analysis]
211 D’mello C, Swain MG. Immune-to-Brain Communication Pathways in Inflammation-Associated Sickness and Depression. In: Dantzer R, Capuron L, editors. Inflammation-Associated Depression: Evidence, Mechanisms and Implications. Cham: Springer International Publishing; 2017. pp. 73-94. [DOI: 10.1007/7854_2016_37] [Cited by in Crossref: 95] [Cited by in F6Publishing: 74] [Article Influence: 13.6] [Reference Citation Analysis]
212 Altmann F, Kosma P, O'Callaghan A, Leahy S, Bottacini F, Molloy E, Plattner S, Schiavi E, Gleinser M, Groeger D, Grant R, Rodriguez Perez N, Healy S, Svehla E, Windwarder M, Hofinger A, O'Connell Motherway M, Akdis CA, Xu J, Roper J, van Sinderen D, O'Mahony L. Genome Analysis and Characterisation of the Exopolysaccharide Produced by Bifidobacterium longum subsp. longum 35624™. PLoS One 2016;11:e0162983. [PMID: 27656878 DOI: 10.1371/journal.pone.0162983] [Cited by in Crossref: 63] [Cited by in F6Publishing: 64] [Article Influence: 9.0] [Reference Citation Analysis]
213 Odamaki T, Kato K, Sugahara H, Xiao J, Abe F, Benno Y. Effect of probiotic yoghurt on animal-based diet-induced change in gut microbiota: an open, randomised, parallel-group study. Beneficial Microbes 2016;7:473-84. [DOI: 10.3920/bm2015.0173] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 3.1] [Reference Citation Analysis]
214 Martin-Viñas JJ, Quigley EM. Immune response in irritable bowel syndrome: A systematic review of systemic and mucosal inflammatory mediators. J Dig Dis 2016;17:572-81. [PMID: 27426409 DOI: 10.1111/1751-2980.12379] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 4.4] [Reference Citation Analysis]
215 O'Neill CA, Monteleone G, McLaughlin JT, Paus R. The gut-skin axis in health and disease: A paradigm with therapeutic implications. Bioessays 2016;38:1167-76. [PMID: 27554239 DOI: 10.1002/bies.201600008] [Cited by in Crossref: 171] [Cited by in F6Publishing: 179] [Article Influence: 24.4] [Reference Citation Analysis]
216 Hayley S, Audet M, Anisman H. Inflammation and the microbiome: implications for depressive disorders. Current Opinion in Pharmacology 2016;29:42-6. [DOI: 10.1016/j.coph.2016.06.001] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 3.4] [Reference Citation Analysis]
217 Giloteaux L, Goodrich JK, Walters WA, Levine SM, Ley RE, Hanson MR. Reduced diversity and altered composition of the gut microbiome in individuals with myalgic encephalomyelitis/chronic fatigue syndrome. Microbiome 2016;4:30. [PMID: 27338587 DOI: 10.1186/s40168-016-0171-4] [Cited by in Crossref: 182] [Cited by in F6Publishing: 186] [Article Influence: 26.0] [Reference Citation Analysis]
218 Buigues C, Fernández-Garrido J, Pruimboom L, Hoogland AJ, Navarro-Martínez R, Martínez-Martínez M, Verdejo Y, Mascarós MC, Peris C, Cauli O. Effect of a Prebiotic Formulation on Frailty Syndrome: A Randomized, Double-Blind Clinical Trial. Int J Mol Sci 2016;17:E932. [PMID: 27314331 DOI: 10.3390/ijms17060932] [Cited by in Crossref: 92] [Cited by in F6Publishing: 101] [Article Influence: 13.1] [Reference Citation Analysis]
219 Buigues C, Fernández-garrido J, Pruimboom L, Hoogland A, Navarro-martínez R, Martínez-martínez M, Verdejo Y, Mascarós M, Peris C, Cauli O. Effect of a Prebiotic Formulation on Frailty Syndrome: A Randomized, Double-Blind Clinical Trial. IJMS 2016;17:932. [DOI: 10.3390/ijms17060932] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
220 Odamaki T, Kato K, Sugahara H, Hashikura N, Takahashi S, Xiao JZ, Abe F, Osawa R. Age-related changes in gut microbiota composition from newborn to centenarian: a cross-sectional study. BMC Microbiol. 2016;16:90. [PMID: 27220822 DOI: 10.1186/s12866-016-0708-5] [Cited by in Crossref: 670] [Cited by in F6Publishing: 696] [Article Influence: 95.7] [Reference Citation Analysis]
221 Katayama T. Host-derived glycans serve as selected nutrients for the gut microbe: human milk oligosaccharides and bifidobacteria†. Bioscience, Biotechnology, and Biochemistry 2016;80:621-32. [DOI: 10.1080/09168451.2015.1132153] [Cited by in Crossref: 67] [Cited by in F6Publishing: 51] [Article Influence: 9.6] [Reference Citation Analysis]
222 Thomas LV, Suzuki K, Zhao J. Probiotics: a proactive approach to health. A symposium report. Br J Nutr 2015;114 Suppl 1:S1-15. [PMID: 26548336 DOI: 10.1017/S0007114515004043] [Cited by in Crossref: 33] [Cited by in F6Publishing: 36] [Article Influence: 4.7] [Reference Citation Analysis]
223 Kirchgessner A. The Role of the Microbiota and Potential for Dietary Intervention in Chronic Fatigue Syndrome. The Gut-Brain Axis 2016. [DOI: 10.1016/b978-0-12-802304-4.00021-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
224 Thomas A, Quigley E. Dietary Interventions and Irritable Bowel Syndrome. The Gut-Brain Axis 2016. [DOI: 10.1016/b978-0-12-802304-4.00020-7] [Reference Citation Analysis]
225 Mizuta M, Endo I, Yamamoto S, Inokawa H, Kubo M, Udaka T, Sogabe O, Maeda H, Shirakawa K, Okazaki E, Odamaki T, Abe F, Xiao JZ. Perioperative supplementation with bifidobacteria improves postoperative nutritional recovery, inflammatory response, and fecal microbiota in patients undergoing colorectal surgery: a prospective, randomized clinical trial. Biosci Microbiota Food Health 2016;35:77-87. [PMID: 27200261 DOI: 10.12938/bmfh.2015-017] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 3.5] [Reference Citation Analysis]
226 Staudacher H. Probiotics for lactose intolerance and irritable bowel syndrome. Br J Community Nurs 2015;Suppl Nutrition:S12, S14. [PMID: 26087202 DOI: 10.12968/bjcn.2015.20.Sup6a.S12] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
227 Quigley EM. Probiotics in Irritable Bowel Syndrome: The Science and the Evidence. J Clin Gastroenterol 2015;49 Suppl 1:S60-4. [PMID: 26447967 DOI: 10.1097/MCG.0000000000000348] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 2.8] [Reference Citation Analysis]
228 Jackson ML, Butt H, Ball M, Lewis DP, Bruck D. Sleep quality and the treatment of intestinal microbiota imbalance in Chronic Fatigue Syndrome: A pilot study. Sleep Sci 2015;8:124-33. [PMID: 26779319 DOI: 10.1016/j.slsci.2015.10.001] [Cited by in Crossref: 35] [Cited by in F6Publishing: 26] [Article Influence: 4.4] [Reference Citation Analysis]
229 D'Mello C, Ronaghan N, Zaheer R, Dicay M, Le T, MacNaughton WK, Surrette MG, Swain MG. Probiotics Improve Inflammation-Associated Sickness Behavior by Altering Communication between the Peripheral Immune System and the Brain. J Neurosci. 2015;35:10821-10830. [PMID: 26224864 DOI: 10.1523/jneurosci.0575-15.2015] [Cited by in Crossref: 113] [Cited by in F6Publishing: 119] [Article Influence: 14.1] [Reference Citation Analysis]
230 Kawahara T, Takahashi T, Oishi K, Tanaka H, Masuda M, Takahashi S, Takano M, Kawakami T, Fukushima K, Kanazawa H, Suzuki T. Consecutive oral administration of Bifidobacterium longum MM-2 improves the defense system against influenza virus infection by enhancing natural killer cell activity in a murine model. Microbiol Immunol 2015;59:1-12. [PMID: 25400245 DOI: 10.1111/1348-0421.12210] [Cited by in Crossref: 70] [Cited by in F6Publishing: 71] [Article Influence: 8.8] [Reference Citation Analysis]
231 Reid G. The growth potential for dairy probiotics. International Dairy Journal 2015;49:16-22. [DOI: 10.1016/j.idairyj.2015.04.004] [Cited by in Crossref: 50] [Cited by in F6Publishing: 51] [Article Influence: 6.3] [Reference Citation Analysis]
232 Vulevic J, Juric A, Walton GE, Claus SP, Tzortzis G, Toward RE, Gibson GR. Influence of galacto-oligosaccharide mixture (B-GOS) on gut microbiota, immune parameters and metabonomics in elderly persons. Br J Nutr 2015;114:586-95. [PMID: 26218845 DOI: 10.1017/S0007114515001889] [Cited by in Crossref: 177] [Cited by in F6Publishing: 180] [Article Influence: 22.1] [Reference Citation Analysis]
233 Strisciuglio C, Miele E, Giugliano FP, Vitale S, Andreozzi M, Vitale A, Catania MR, Staiano A, Troncone R, Gianfrani C. Bifidobacteria Enhance Antigen Sampling and Processing by Dendritic Cells in Pediatric Inflammatory Bowel Disease. Inflamm Bowel Dis 2015;21:1491-8. [PMID: 25895109 DOI: 10.1097/MIB.0000000000000389] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
234 L. M. S, Kyiv Taras Shevchenko National University. IMMUNOMODULATORY PROPERTIES OF THE HUMAN INTESTINAL MICROBIOTA AND PROSPECTS FOR THE USE OF PROBIOTICS FOR PROPHYLAXIS AND CORRECTION OF INFLAMMATORY PROCESSES. Biotechnol acta 2015;8:28-44. [DOI: 10.15407/biotech8.03.028] [Reference Citation Analysis]
235 O'Mahony L. Host-microbiome interactions in health and disease. Clin Liver Dis (Hoboken) 2015;5:142-4. [PMID: 31040971 DOI: 10.1002/cld.484] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
236 Yoshimatsu Y, Yamada A, Furukawa R, Sono K, Osamura A, Nakamura K, Aoki H, Tsuda Y, Hosoe N, Takada N, Suzuki Y. Effectiveness of probiotic therapy for the prevention of relapse in patients with inactive ulcerative colitis. World J Gastroenterol 2015; 21(19): 5985-5994 [PMID: 26019464 DOI: 10.3748/wjg.v21.i19.5985] [Cited by in CrossRef: 78] [Cited by in F6Publishing: 78] [Article Influence: 9.8] [Reference Citation Analysis]
237 Patel S, Shukla R, Goyal A. Probiotics in valorization of innate immunity across various animal models. Journal of Functional Foods 2015;14:549-61. [DOI: 10.1016/j.jff.2015.02.022] [Cited by in Crossref: 31] [Cited by in F6Publishing: 22] [Article Influence: 3.9] [Reference Citation Analysis]
238 Braundmeier AG, Lenz KM, Inman KS, Chia N, Jeraldo P, Walther-António MR, Berg Miller ME, Yang F, Creedon DJ, Nelson H, White BA. Individualized medicine and the microbiome in reproductive tract. Front Physiol 2015;6:97. [PMID: 25883569 DOI: 10.3389/fphys.2015.00097] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 3.6] [Reference Citation Analysis]
239 Dietert RR, Dietert JM. The Microbiome and Sustainable Healthcare. Healthcare (Basel) 2015;3:100-29. [PMID: 27417751 DOI: 10.3390/healthcare3010100] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 3.8] [Reference Citation Analysis]
240 Frei R, Akdis M, O'Mahony L. Prebiotics, probiotics, synbiotics, and the immune system: experimental data and clinical evidence. Curr Opin Gastroenterol 2015;31:153-8. [PMID: 25594887 DOI: 10.1097/MOG.0000000000000151] [Cited by in Crossref: 150] [Cited by in F6Publishing: 153] [Article Influence: 18.8] [Reference Citation Analysis]
241 Saez-Lara MJ, Gomez-Llorente C, Plaza-Diaz J, Gil A. The role of probiotic lactic acid bacteria and bifidobacteria in the prevention and treatment of inflammatory bowel disease and other related diseases: a systematic review of randomized human clinical trials. Biomed Res Int. 2015;2015:505878. [PMID: 25793197 DOI: 10.1155/2015/505878] [Cited by in Crossref: 185] [Cited by in F6Publishing: 167] [Article Influence: 23.1] [Reference Citation Analysis]
242 Arat S, Spivak A, Van Horn S, Thomas E, Traini C, Sathe G, Livi GP, Ingraham K, Jones L, Aubart K, Holmes DJ, Naderer O, Brown JR. Microbiome changes in healthy volunteers treated with GSK1322322, a novel antibiotic targeting bacterial peptide deformylase. Antimicrob Agents Chemother 2015;59:1182-92. [PMID: 25487798 DOI: 10.1128/AAC.04506-14] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
243 Scuotto A, Djorie S, Colavizza M, Romond PC, Romond MB. Bifidobacterium breve C50 secretes lipoprotein with CHAP domain recognized in aggregated form by TLR2. Biochimie 2014;107 Pt B:367-75. [PMID: 25457102 DOI: 10.1016/j.biochi.2014.10.007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
244 Quigley EM, Shanahan F. The future of probiotics for disorders of the brain-gut axis. Adv Exp Med Biol 2014;817:417-32. [PMID: 24997045 DOI: 10.1007/978-1-4939-0897-4_19] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
245 Tojo R, Suárez A, Clemente MG, de los Reyes-Gavilán CG, Margolles A, Gueimonde M, Ruas-Madiedo P. Intestinal microbiota in health and disease: Role of bifidobacteria in gut homeostasis. World J Gastroenterol 2014; 20(41): 15163-15176 [PMID: 25386066 DOI: 10.3748/wjg.v20.i41.15163] [Cited by in CrossRef: 285] [Cited by in F6Publishing: 299] [Article Influence: 31.7] [Reference Citation Analysis]
246 Marlicz W, Loniewski I, Grimes DS, Quigley EM. Nonsteroidal anti-inflammatory drugs, proton pump inhibitors, and gastrointestinal injury: Contrasting interactions in the stomach and small intestine. Mayo Clin Proc. 2014;89:1699-1709. [PMID: 25440891 DOI: 10.1016/j.mayocp.2014.07.015] [Cited by in Crossref: 51] [Cited by in F6Publishing: 55] [Article Influence: 5.7] [Reference Citation Analysis]
247 Floch MH. Recommendations for probiotic use in humans-a 2014 update. Pharmaceuticals (Basel). 2014;7:999-1007. [PMID: 25310351 DOI: 10.3390/ph7100999] [Cited by in Crossref: 44] [Cited by in F6Publishing: 45] [Article Influence: 4.9] [Reference Citation Analysis]
248 Kumar A, Hecht C, Priyamvada S, Anbazhagan AN, Alakkam A, Borthakur A, Alrefai WA, Gill RK, Dudeja PK. Probiotic Bifidobacterium species stimulate human SLC26A3 gene function and expression in intestinal epithelial cells. Am J Physiol Cell Physiol 2014;307:C1084-92. [PMID: 25143346 DOI: 10.1152/ajpcell.00194.2014] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 3.1] [Reference Citation Analysis]
249 Moran CP, Shanahan F. Gut microbiota and obesity: role in aetiology and potential therapeutic target. Best Pract Res Clin Gastroenterol 2014;28:585-97. [PMID: 25194177 DOI: 10.1016/j.bpg.2014.07.005] [Cited by in Crossref: 78] [Cited by in F6Publishing: 80] [Article Influence: 8.7] [Reference Citation Analysis]
250 Chen SJ, Liu XW, Liu JP, Yang XY, Lu FG. Ulcerative colitis as a polymicrobial infection characterized by sustained broken mucus barrier. World J Gastroenterol 2014; 20(28): 9468-9475 [PMID: 25071341 DOI: 10.3748/wjg.v20.i28.9468] [Cited by in CrossRef: 36] [Cited by in F6Publishing: 41] [Article Influence: 4.0] [Reference Citation Analysis]
251 Shanahan F, Quigley EM. Manipulation of the microbiota for treatment of IBS and IBD-challenges and controversies. Gastroenterology 2014;146:1554-63. [PMID: 24486051 DOI: 10.1053/j.gastro.2014.01.050] [Cited by in Crossref: 125] [Cited by in F6Publishing: 128] [Article Influence: 13.9] [Reference Citation Analysis]
252 Tillisch K. The effects of gut microbiota on CNS function in humans. Gut Microbes 2014;5:404-10. [PMID: 24838095 DOI: 10.4161/gmic.29232] [Cited by in Crossref: 97] [Cited by in F6Publishing: 97] [Article Influence: 10.8] [Reference Citation Analysis]
253 Twisk FN. The status of and future research into Myalgic Encephalomyelitis and Chronic Fatigue Syndrome: the need of accurate diagnosis, objective assessment, and acknowledging biological and clinical subgroups. Front Physiol. 2014;5:109. [PMID: 24734022 DOI: 10.3389/fphys.2014.00109] [Cited by in Crossref: 28] [Cited by in F6Publishing: 32] [Article Influence: 3.1] [Reference Citation Analysis]
254 Moloney RD, Desbonnet L, Clarke G, Dinan TG, Cryan JF. The microbiome: stress, health and disease. Mamm Genome. 2014;25:49-74. [PMID: 24281320 DOI: 10.1007/s00335-013-9488-5] [Cited by in Crossref: 279] [Cited by in F6Publishing: 228] [Article Influence: 27.9] [Reference Citation Analysis]
255 Quigley EM. Commentary: synbiotics and gut microbiota in older people--a microbial guide to healthy ageing. Aliment Pharmacol Ther 2013;38:1141-2. [PMID: 24099479 DOI: 10.1111/apt.12495] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
256 Rosenberg E, Zilber-rosenberg I. Prebiotics, Probiotics, Synbiotics, and Phage Therapy. The Hologenome Concept: Human, Animal and Plant Microbiota 2013. [DOI: 10.1007/978-3-319-13904-3_10] [Reference Citation Analysis]
257 Rosenberg E, Zilber-rosenberg I. Prebiotics, Probiotics, Synbiotics, and Phage Therapy. The Hologenome Concept: Human, Animal and Plant Microbiota 2013. [DOI: 10.1007/978-3-319-04241-1_10] [Reference Citation Analysis]